Eagle Pharmaceuticals, Inc. (EGRX)
NASDAQ: EGRX · IEX Real-Time Price · USD
3.740
+0.010 (0.27%)
At close: May 24, 2024, 4:00 PM
3.600
-0.140 (-3.74%)
After-hours: May 24, 2024, 7:58 PM EDT

Eagle Pharmaceuticals Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for EGRX stock has a target of 17, which predicts an increase of 354.55% from the current stock price of 3.74.

Analyst Consensus: Sell
Target Low Average Median High
Price $17 $17 $17 $17
Change +354.55% +354.55% +354.55% +354.55%
* Price targets were last updated on Aug 9, 2023.

Analyst Ratings

According to 1 stock analyst, the rating for EGRX is "Sell". This means that the analyst believes this stock is likely to lead to lower returns than market as a whole.

Recommendation Trends

Rating Dec '23Jan '24Feb '24Mar '24Apr '24May '24
Strong Buy 000000
Buy 000000
Hold 000000
Sell 111111
Strong Sell 000000
Total 111111

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Piper Sandler
Piper Sandler
Sell
Downgrades
$26$17
Sell Downgrades $26$17 +354.55% Aug 9, 2023
Cantor Fitzgerald
Cantor Fitzgerald
Hold
Maintains
n/a
Hold Maintains n/a n/a Mar 2, 2020
Mizuho
Mizuho
Hold
Maintains
n/a
Hold Maintains n/a n/a Mar 22, 2019
Piper Sandler
Piper Sandler
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Oct 31, 2018
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Maintains
n/a
Buy Maintains n/a n/a Sep 21, 2018
More Analyst Ratings

Financial Forecast

Revenue This Year
263.51M
from 316.61M
Decreased by -16.77%
Revenue Next Year
215.73M
from 263.51M
Decreased by -18.13%
EPS This Year
4.67
from 2.73
Increased by 71.12%
EPS Next Year
3.34
from 4.67
Decreased by -28.60%
Year 20182019202020212022202320242025
Revenue
213.31M195.89M187.80M171.55M316.61M263.51M215.73M228.48M
Revenue Growth
-9.88%-8.17%-4.13%-8.66%84.56%-16.77%-18.13%5.91%
EPS
2.091.010.87-0.662.734.673.343.05
EPS Growth
-36.09%-51.67%-13.86%--71.12%-28.60%-8.56%
No. Analysts -----333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202320242025
High 271.3M 222.1M 235.2M
Avg 263.5M 215.7M 228.5M
Low 253.2M 207.3M 219.5M

Revenue Growth

Revenue Growth 202320242025
High
-14.3%
-15.7%
9.0%
Avg
-16.8%
-18.1%
5.9%
Low
-20.0%
-21.3%
1.8%

EPS Forecast

EPS 202320242025
High 4.81 3.43 3.14
Avg 4.67 3.34 3.05
Low 4.49 3.20 2.93

EPS Growth

EPS Growth 202320242025
High
76.2%
-26.5%
-5.9%
Avg
71.1%
-28.6%
-8.6%
Low
64.4%
-31.4%
-12.1%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.